Iovance Biotherapeutics Market Cap

Iovance Biotherapeutics has a market cap or net worth of €750.71 million as of December 5, 2025. Its market cap has decreased by -69.12% in one year.

Market Cap

750.71M

Enterprise Value

537.27M

Revenue

213.44M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.89

Market Cap Chart

Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 73.63M to 750.71M, an increase of 919.64%. That is a compound annual growth rate of 16.12%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	748.88M	-65.62%
Dec 31, 2024	2.18B	15.73%
Dec 29, 2023	1.88B	99.45%
Dec 30, 2022	943.75M	-64.17%
Dec 31, 2021	2.63B	-52.67%
Dec 31, 2020	5.56B	78.76%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	248.18B
Siemens Aktiengesellschaft	179.36B
Allianz SE	139.43B
Deutsche Telekom AG	131.24B
Siemens Energy AG	99.98B
Rheinmetall AG	70.18B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.26B
Deutsche Bank Aktiengesellschaft	59.33B

Market Cap Rankings